This provides evidence that our platform can be used as a versatile, rapid and promising model to study dominantly-inherited neurodegenerative diseases including ALS (TDP43)10 and PD (α-synuclein and LRRK2)7,8. This evidence concerns the gene LRRK2 and Parkinson disease.